Search | Page 16 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation

    ... is to investigate the safety and overall efficacy of azacitidine in reducing the incidence and severity of GvHD when added to ... Associated Drug(s):  Azacitidine Cyclophosphamide Fludarabine ...

    Clinical Trial last updated 05/03/2016 - 11:15am.

  2. Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation

    ... to determine whether post-transplant consolidation with azacitidine combined with donor lymphocyte infusion (DLI) is a safe ... Associated Drug(s):  Azacitidine Phase:  ...

    Clinical Trial last updated 04/28/2016 - 10:42am.

  3. Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia

    ... Associated Drug(s):  Azacitidine Lenalidomide ... Known or suspected hypersensitivity to azacitidine or mannitol Patients with advanced malignant hepatic ...

    Clinical Trial last updated 06/06/2016 - 1:30pm.

  4. Therapy-related Myelodysplastic Syndrome: an analysis of 5 risk models in patients treated with azacitidine

    ... and for how long), 84 t-MDS patients treated with azacitidine were evaluated with 5 different scoring systems.  A scoring ... of using this scoring system on t-MDS patients treated with azacitidine.  (A prospective study is a study in which the outcome of a ...

    Research Review last updated 05/02/2016 - 9:28am.

  5. CC-486 (Oral Azacitidine) Bioequivalence Study in Patients With Solid Tumor or Hematologic Malignancies

    ... Associated Drug(s):  Azacitidine Phase:  ... every 4 weeks for ≤ 6 (four-week) cycles Other Names: Azacitidine for Injection AZA ...

    Clinical Trial last updated 04/28/2016 - 10:47am.

  6. Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission (QUAZAR AML-001)

    ... Associated Drug(s):  Azacitidine Phase:  ... Intervention:  Drug: 300 mg Oral Azacitidine Maintenance therapy Drug: Placebo ...

    Clinical Trial last updated 04/29/2016 - 8:39am.

  7. AAMDSIF Summer Fellowship Grant Program

    ... investigated DNA response to two drugs, vosaroxin and azacitidine , by comparing samples of patient DNA before and after ... in tumor cells caused by vosaroxin and an additional drug, azacitidine, which is currently the frontline therapy for MDS. We will ...

    Page last updated 05/17/2017 - 1:29pm.

  8. AC220 With 5-Aza or Low Dose Cytarabine

    ... of AC220 (quizartinib) that can be given with either 5- azacitidine (azacitidine) or cytarabine to patients with AML or MDS. The goal of the ...

    Clinical Trial last updated 05/03/2016 - 11:11am.

  9. A Safety and Pharmacology Study of Atezolizumab (MPDL3280A, Anti-PD-L1 Antibody) Administered Alone or in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

    ... populations, including treatment in combination with azacitidine . Status:  ... Associated Drug(s):  Azacitidine Phase:  ...

    Clinical Trial last updated 04/27/2016 - 9:57am.

  10. Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

    ... Phase II trial combining azacitidine with valproic acid as maintenance therapy post allogeneic stem ... MDS/AML. We hypothesize that adding valproic acid to azacitidine will improve outcomes via both direct anti-tumor and ... is near 40%. We hypothesize that valproic acid and azacitidine will prolong survival, with a 1 year survival goal of 60%. In ...

    Clinical Trial last updated 04/29/2016 - 12:35pm.